Beacon Capital Management Inc (Ohio)’s AbbVie ABBV Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-60	Closed	-$13.9K	–	139
2025 Q3	$13.9K	Buy	+60	New	+$12.2K	﹤0.01%	94
2022 Q4	–	Sell	-50	Closed	-$7K	–	105
2022 Q3	$7K	Buy	+50	New	+$7.17K	﹤0.01%	56
2018 Q1	–	Sell	-11	Closed	-$1K	–	76
2017 Q4	$1K	Buy	+11	New	+$1.04K	﹤0.01%	57
2016 Q1	–	Sell	-5	Closed	–	–	184
2015 Q4	$0	Buy	5 +3	+150%	+$173	﹤0.01%	239
2015 Q3	$0	Buy	+2	New	+$130	﹤0.01%	234

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s ABBV Position: Q4 2025 in Review

Beacon Capital Management Inc (Ohio) sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 60 shares — an estimated $13.9K sold.

Beacon Capital Management Inc (Ohio) first reported a position in ABBV in Q3 2015 and held it in 5 quarters. The position peaked at $13.9K in Q3 2025. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Beacon Capital Management Inc (Ohio) reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Beacon Capital Management Inc (Ohio) sold 60 AbbVie shares in Q4 2025, an estimated $13.9K.
Beacon Capital Management Inc (Ohio) first reported a position in AbbVie in Q3 2015 and held it in 5 quarters.
Beacon Capital Management Inc (Ohio)'s AbbVie position peaked at $13.9K in Q3 2025.
4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q4 2025, filed 12 Feb 2026.